Financials
SEC Filings
Stock Price
Board of Directors
Mark Wendland
+ Chairman of the Board
Mark Wendland has served as a member of our board of directors since November 2025. Mr. Wendland is currently the Chairman of the Board. He was appointed as Chief Executive Officer of the Company and as a director of the Board effective November 6, 2025. Prior to that, Mr. Wendland served in various roles at DRW Holdings LLC, a proprietary trading firm, from July 2019 to June of 2025. Mr. Wendland served as Partner from January 2023 to June 2025, Chief Operating Officer from September 2021 to June of 2025, and Global Treasurer from July 2019 to September 2021. Prior to his time at DRW Holdings LLC, Mr. Wendland served as a Global Treasury Manager at Citadel LLC, a hedge fund and financial services company from September 2003 to January 2019. Mr. Wendland received his B.S. in Business Administration from Carroll College.
Vincent Lopriore
Vincent LoPriore has served as a member of our board of directors since April 2025. Mr. LoPriore is an experienced financial professional with over 30 years of experience in the investment banking industry. He began his career at Oppenheimer & Co. in 1989 and subsequently held senior positions at Legg Mason, Inc. and partner at C.E. Unterberg, Towbin, where he led the special equities group and completed more than $150 million in private placement transactions. He has served in leadership roles at various boutique and mid-sized investment firms, focusing on capital raising, regulatory navigation. Mr. LoPriore is currently a Partner and licensed representative at President Street Global, LLC, a FINRA-registered broker-dealer. He also serves as the investment manager of the Gravitas Capital LP Fund, with a track record of strong investment performance. Mr. LoPriore has longstanding relationships within the biomedical industry and supports philanthropic initiatives including Race to Erase MS and Cure Addiction Now. Mr. LoPriore’s extensive investment banking experience and sector expertise support his qualifications to serve on the Board of Directors.
gary Stetz
+ Independent Director
Gary Stetz has served as a member of our board of directors since April 2025. Mr. Stetz is a Certified Public Accountant with over 35 years of experience across accounting, finance, business valuation and corporate governance. Mr. Stetz currently serves as Managing Partner of Stetz, Belgiovine, Manwarren and Wallis P.C., an accounting, auditing, tax compliance and advisory services firm with more than 1,000 corporate clients. His extensive leadership experience includes founding Allegiance Community Bank and serving on the Board of BCB Bancorp. He is co-author of the book Project Management Accounting. He has earned multiple professional credentials, including Certified Mediator, Certified Fraud Examiner, and Chartered Global Management Accountant Mr. Stetz’s extensive expertise in financial forensics, valuation, and regulatory compliance will provide valuable oversight as Tharimmune continues to build a strong financial and operational foundation. Mr. Stetz’s extensive financial, accounting, and governance experience supports his qualifications to serve on the Board of Directors.
Clay Kahler
+ Independent Director
Clay Kahler has served as a member of our board of directors since April 2025. Mr. Kahler is a seasoned entrepreneur with decades of leadership experience in life sciences, biotechnology, and technology ventures. He is the Co-founder, CEO, and Managing Director of Spray Labs, LLC, an FDA-registered, cGMP-certified manufacturer specializing in oral spray drug delivery technologies. He is also the Founder and CEO of Gateway Sciences LLC, a company focused on regenerative medicine and mental health. Mr. Kahler co-founded Helius Medical Technologies, Inc. (NASDAQ: HSDT), where he played a pivotal role in structuring early corporate financing, facilitating the company’s public listing, and establishing strategic partnerships including worked with the team to secure a multi-million dollar Cooperative Research and Development Agreement (CRADA) with the U.S. Department of Defense, through the U.S. Army Medical Research and Materiel Command (USAMRMC). These efforts helped propel the company to a peak market capitalization of approximately $500 million. He has also held multiple corporate advisory positions including UK-based Velocity Mobile Limited, doing business as Velocity Black, which was successfully acquired by Capital One Financial Corporation (NYSE: COF) in June 2023 for approximately $300 million. Mr. Kahler’s extensive leadership experience in public company operations, capital markets, and life sciences supports his qualifications to serve on the Board of Directors.
Sireesh Appajosyula
Sireesh Appajosyula currently is CEO of the Gravitas Life Sciences division. He served as Tharimmune, Inc. CEO from June of 2025 to November 6, 2025 and joined as COO in July of 2023 while serving as a member of our board of directors since July 2021. Previously, he was SVP, Corporate Development and Operations of 9 Meters Biopharma, a company focused on rare and unmet needs and is Managing Member of Highpoint Pharmaceuticals, LLC, a pharmaceutical research and development company. Prior to 9 Meters, Dr. Appajosyula was at Salix Pharmaceuticals, Inc. (“Salix”) (Nasdaq: SLXP) in various roles in medical affairs, product commercialization and business development until its acquisition by Bausch Health (Nasdaq: BHC). Prior to Salix, he was involved in various roles at Amgen Inc., Critical Therapeutics, Inc. (now Chiesi) and Sanofi (formerly Aventis). Dr. Appajosyula received his Bachelor of Science and Doctor of Pharmacy from Rutgers University.
Jill Sommers
+ Independent Director
Jill Sommers has nearly three decades of experience in derivatives and financial markets, including serving two consecutive terms as a Commissioner of the U.S. Commodity Futures Trading Commission (“CFTC”). She most recently served as the Chair of the Derivative Practice Group of Potamak Global Partners until March 2025. Earlier in her career, Ms. Sommers held several senior policy and regulatory roles, including Policy Director and Head of Government Affairs at the International Swaps and Derivatives Association (“ISDA”) and Managing Director of Regulatory Affairs at the Chicago Mercantile Exchange.
William Wiley
+ Independent Director
William Wiley has deep capital markets experience as well as a track record leading complex global operations, including in his current role as Head of the Equities and Latency Sensitive Business Unit at DRW and Chief of Staff to DRW’s Founder and Chief Executive Officer. Mr. Wiley previously served as Chief Operating Officer of DRW’s Equities and Latency Sensitive Business Unit, overseeing day-to-day operations and scaling a global, multi-asset electronic trading platform. Prior to DRW, Mr. Wiley served as Global Head of Strategy at Instinet Holdings Inc. where he led firmwide strategy, operations, and strategic transactions across the institutional equities brokerage franchise.
+ Independent Director
Clay Kahler has served as a member of our board of directors since April 2025. Mr. Kahler is an entrepreneur and executive with experience across life sciences, biotechnology, and emerging technologies. He is the Co-founder, Chief Executive Officer, and Managing Director of Spray Labs, LLC, an FDA-registered, cGMP-certified manufacturer specializing in oral spray drug delivery systems, and the Founder and Chief Executive Officer of Gateway Sciences LLC, focused on mental health and regenerative medicine. Mr. Kahler co-founded Helius Medical Technologies, Inc. (NASDAQ: HSDT), where he contributed to early-stage financing, capital markets strategy, and public market development, including a Cooperative Research and Development Agreement (CRADA) with the U.S. Army. Helius achieved significant public market scale during his involvement. He has also been active in U.S. and Canadian public markets across innovative life sciences and emerging technologies, including Gener8 Digital Media Corp., where he supported strategic initiatives leading to the sale of its studio assets to Reliance MediaWorks, part of a global media group, and Velocity Mobile Limited (Velocity Black), which was acquired by Capital One Financial Corporation (NYSE: COF) in 2023.
+ Independent Director
Jill E. Sommers has served as a member of our board of directors since January 2026. Ms. Sommers is an experienced regulatory and public policy professional with nearly three decades of experience in the derivatives and financial markets. She previously served as the Chair of the Derivative Practice Group of Patomak Global Partners until March 2025. Ms. Sommers also served two consecutive terms as a Commissioner of the Commodity Futures Trading Commission from 2007 to 2013. Earlier in her career, Ms. Sommers held senior policy and regulatory roles, including serving as Policy Director and Head of Government Affairs at the International Swaps and Derivatives Association and as Managing Director of Regulatory Affairs at the Chicago Mercantile Exchange. Ms. Sommers currently serves on the boards of directors of Robinhood VF, Miami International Holdings as well as other private companies. She has also served as a board member of Cboe Global Markets, Inc. and the National Futures Association. Ms. Sommers holds a B.A. in Political Science from the University of Kansas. Ms. Sommers brings to the Board extensive experience in derivatives regulation, corporate governance, and public policy.
+ Independent Director
William Wiley has served as a member of our board of directors since January 2026. Mr. Wiley has served as Head of the Equities and Latency Sensitive Business Unit of DRW Holdings, LLC (“DRW”) since October 2025 and has also served as Chief of Staff to DRW’s Founder and Chief Executive Officer since February 2025. From August 2022 to October 2025, Mr. Wiley served as Chief Operating Officer of DRW’s Equities and Latency Sensitive Business Unit, overseeing day-to-day operations and scaling a global, multi-asset electronic trading platform. Prior to DRW, Mr. Wiley served as Global Head of Strategy at Instinet Holdings Inc. (“Instinet”) from April 2018 to August 2022, where he was a member of Instinet’s Global Executive Committee and led firmwide strategy, operations, and strategic transactions across the institutional equities brokerage franchise. From 2010 to 2017, Mr. Wiley held a series of roles at KCG Holdings, Inc. (“KCG”), including Chief Operating Officer of Client Execution Services from September 2013 to July 2017. Mr. Wiley received a B.S. in Business Administration and a B.S. in Economics from Villanova University and is a Chartered Financial Analyst (CFA) charterholder.
+ Independent Director
Sean Galvin has more than 35 years of experience in the accounting and financial services fields. He served as Senior Managing Director and Chief Administrative Officer of Nearwater Capital Management from April 2025 through September 2025. Mr. Galvin served as Executive Vice President of Virtu Financial, Inc. from August 2020 through April 2025, and as Virtu’s Chief Financial Officer from 2020 through August 2024. Previously, he served as the Chief Accounting Officer of BGC Partners, Inc., a global financial services company, from September 2018 to August 2020. He also served in various roles at KCG which was acquired by Virtu in July 2017, from 2000 until May 2018. Prior to joining KCG in 2000, Mr. Galvin was a Vice President at Donaldson, Lufkin & Jenrette and a Senior Tax Manager at PricewaterhouseCoopers LLP. Mr. Galvin earned a M.S. in Taxation from Fordham University as well as a B.S. in Accounting and Information Systems with a minor in Economics from Queens College, CUNY. Mr. Galvin is a Certified Public Accountant.
+ Independent Director
Pamela Carter served for 18 years at Cummins Inc., a global power technology leader specializing in diesel, alternative fuel engines, power generators, related components and technology, from 1997 until her retirement in 2015. Ms. Carter held executive positions including Vice President, General Counsel, and Corporate Secretary, President of Cummins Filtration business unit, and President of Cummins Distribution business unit during her time of service. She serves as Chair of the Human Resource and Compensation Committee, as a member of the Audit Committee and as member of the Integration Committee for Hewlett Packard Enterprise. Ms. Carter served as Chair of the Board of Enbridge Inc., a global energy infrastructure company; and as Audit Committee Chair of Broadridge Financial Solutions, Inc., a financial technology company, and Finance & Risk Chair of CSX Inc, a rail-based freight transportation company. Ms. Carter was elected as Indiana’s state attorney general in 1992, making her the first Black female elected to that office in the United States of America, and served until 1997.
+ Independent Director
Rishi Nangalia brings significant experience in capital markets, financial technology, electronic trading, investment banking and trading platform development. Since January 2022, Mr. Nangalia has served as co-founder and Managing Partner of OPCO Advisory Inc., a capital markets fintech advisory and execution firm focused on creating consortia within the fintech ecosystem. From January 2001 to June 2013, Mr. Nangalia served as a Managing Director at Goldman Sachs/REDI, where he worked in investment banking and trading, helping build a leading global electronic trading franchise and taking responsibility for product and business development. Following his tenure at Goldman Sachs/REDI, Mr. Nangalia served as Chief Executive Officer and Founder of REDI Technologies, an electronic trading software company, where he conceived and led a preeminent trading platform. After Thomson Reuters acquired REDI Technologies in 2017, Mr. Nangalia joined Thomson Reuters/Refinitiv, where he served as Global Head of Buy Side Trading until the end of 2019. Mr. Nangalia also serves on the boards of Automated Data Inc., OPCO Advisory and 222 Lake Partners. Mr. Nangalia was a member of the board of directors of Maystreet Inc. from April 2020 to May 2022 and Beacon Platform Inc. from January 2022 to April 2025. He holds an MBA in Finance from Columbia University, and an M.S. in Real Estate from Columbia University. He also holds relevant FINRA licenses.